Monopolar Capacitive-Resistive Radiofrequency for Pelvic Floor Hypertonia and Vaginismus: A Case Series
Abstract
Pelvic floor hypertonia is an important musculoskeletal contributor to chronic pelvic pain and may be associated with genito-pelvic pain/penetration disorders, including vaginismus. We describe a prospective case series of three women aged 31, 32, and 45 years with pelvic floor hypertonia and vaginismus who underwent six weekly treatment sessions using a monopolar capacitive-resistive radiofrequency device (C200; Capenergy Medical, S.L., Sant Joan Despí, Barcelona, Spain). Each session consisted of a 20-minute intracavitary application using the MJS (Medical Jet System) handpiece combined with simultaneous application of an automatic pelvic plate. Outcomes were assessed before treatment and at follow-up using pain scores, the Female Sexual Function Index (FSFI), pelvic floor examination, and functional assessment of vaginal penetration. Baseline pain scores ranged from 8 to 9 out of 10 and decreased to 0 to 1 at follow-up. FSFI total scores increased from a baseline range of 8.3-12.4 to 28.9-31.8 at follow-up. All three patients showed improvement in clinically assessed pelvic floor muscle hypertonia and regained pain-free vaginal penetration, with satisfactory penetrative intercourse reported during follow-up. In this small uncontrolled case series, monopolar capacitive-resistive radiofrequency treatment was associated with clinically relevant improvements in pelvic pain, pelvic floor examination findings, and sexual function. These findings are preliminary and…
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.